Synthetic Peptide-Based Cancer Vaccines: Lessons Learned and Hurdles to Overcome

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|9|6|683-693

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.9, Iss.6, 2009-08, pp. : 683-693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines

By Ghosh S.   Jackson D.C.  

International Immunology, Vol. 11, Iss. 7, 1999-07 ,pp. : 1103-1110

Oxford University Press

Access to resources Recommend Favorite

Determinant spreading and tumor responses after peptide-based cancer immunotherapy

By Ribas A.   Timmerman J.M.   Butterfield L.H.   Economou J.S.  

Trends in Immunology, Vol. 24, Iss. 2, 2003-02 ,pp. : 58-61

Elsevier

Access to resources Recommend Favorite

Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease

By Batzloff Michael   Pandey Manisha   Olive Colleen   Good Michael  

Immunologic Research, Vol. 35, Iss. 3, 2006-10 ,pp. : 233-248

Humana Press, Inc

Access to resources Recommend Favorite

The geometry of synthetic peptide-based immunogens affects the efficiency of T cell stimulation by professional antigen-presenting cells

By Kronin V.  

International Immunology, Vol. 12, Iss. 4, 2000-04 ,pp. : 527-535

Oxford University Press

Access to resources Recommend Favorite

Molecular Bases for the Construction of Artificial Immunogens and Vaccines Based on Synthetic Polyions

By Khaitov Rakhim M.  

Allergy and Asthma Proceedings, Vol. 16, Iss. 5, 1995-09 ,pp. : 255-260

OceanSide Publications, Inc

Access to resources Recommend Favorite